Providing assessment of FDA regulatory issues and risks for customized product line of cosmetic and OTC drug products, including review of applicable manufacturing, labeling, and advertising/promotion requirements.
Achieved a significant win in the UK for Olaplex, an innovative California start-up, in its long-running high-profile patent infringement case.
Advised a global cosmetics manufacturer on a compliance audit of distribution and pricing arrangements under UK and European Union (EU) competition law.
Advised Shop Apotheke Europe N.V. on its initial public offering.
Advising a leading U.S. luxury cosmetics brand on endorsement agreements being signed with celebrities to support advertising campaigns.
Advising a well-known manufacturer and marketer of high-end beauty care products on brand protection and enforcement issues.
Advising Kao Brands on product labeling, claims, and advertising, including promotional terms and conditions and on challenges to competitors' advertising materials.
Advising leading consumer brands including J Brand, Glo Skin Beauty, and Supergoop! with respect to international distribution and supply chain arrangements.
Advising numerous clients on what their labels can say or claim across jurisdictions.
Advising cosmetic and OTC drug manufacturers on CGMP compliance.
Counseled companies on the law surrounding the OTC drug monograph reform, including ingredient status post reform, OMOR submissions, exclusivity, and more.
Advised multiple clients on regulatory issues related to recent FDA guidance on the labeling and manufacture of alcohol-based hand sanitizers during the COVID-19 emergency.
Partner
New York
Partner
London
Partner
Washington, D.C.
Dr. Florian Unseld, LL.M. (Sydney)
Partner
Munich, Dusseldorf
Band 1 for Intellectual Property
Chambers Global
Band 1 for Corporate M&A
Chambers USA
Tier 2 for Industry Focus: Luxury Goods (Italy)
Legal 500 EMEA
